Anavex Life Sciences Corp.
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy

Abstract:

This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one AED. This invention further encompasses a method of treating a subject in need of such treatment comprising administering a therapeutically effective amount of A19-144 or A2-73 in conjunction with an therapeutically effective amount of an AED.